Michael (Mike) Erickson, PhD
Board Member
Idexx Laboratories Inc /De (IDXX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michael (Mike) Erickson, PhD
Michael (Mike) Erickson, PhD is recorded as CEO and Board Member at Idexx Laboratories Inc /De (IDXX). Idexx Laboratories Inc /De reported in an 8-K filed January 13, 2026 that Michael (Mike) Erickson, PhD was appointed Class II Director, effective May 12, 2026. Idexx Laboratories Inc /De reported in an 8-K filed January 13, 2026 that Michael (Mike) Erickson, PhD was appointed President and Chief Executive Officer, effective May 12, 2026.
“Michael (Mike) Erickson, PhD, will assume the role of President and Chief Executive Officer of the Company and join the Board as a Class II Director.”
“Michael (Mike) Erickson, PhD, will assume the role of President and Chief Executive Officer of the Company and join the Board as a Class II Director.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-05-12–present
-
Current
2026-05-12–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Idexx Laboratories Inc /De
Other people whose current roles at this company are on record from its filings.
- Jonathan Mazelsky CEO
- Michael (Mike) Erickson CEO, Board Member
- Jonathan (Jay) Mazelsky Chairman
- Lawrence D. Kingsley Chairman
- Andrew Emerson CFO
- Brian McKeon CFO
- Martin Smith CTO
- Sharon E. Underberg General Counsel
- Asha S. Collins, PhD Board Member
- Bruce L. Claflin Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.